FDA approves first generic version of Mylan's EpiPen
The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's EpiPen for the emergency treatment of allergic reactions.
from Reuters: Health News https://reut.rs/2MX711G
http://bit.ly/2zwRqiM